Preventing HIV infection in women: a global health imperative.

Abdool Karim Q, Sibeko S, Baxter C. Clin Infect Dis. 2010;50(suppl 3):S122-S129.

Brief report: randomized, double-blind comparison of tenofovir alafenamide (TAF) vs tenofovir disoproxil fumarate (TDF), each coformulated with elvitegravir, cobicistat, and emtricitabine (E/C/F) for initial HIV-1 treatment: week 144 results.

Arribas JR, Thompson M, Sax PE, et al. J Acquir Immune Defic Syndr. 2017;75(2):211-218.

Improving care outcomes for PLWH experiencing homelessness and unstable housing: a synthetic review of clinic-based strategies.

Clemenzi-Allen AA, Hickey M, Conte M, et al. Curr HIV/AIDS Rep. 2020;17(3):259-267.

Rapid antiretroviral therapy: time for a new standard of care.

Coffey S, Halperin J, Rana AI, Colasanti JA. Clin Infect Dis. 2020. [Epub ahead of print]

U.S. medical eligibility criteria for contraceptive use, 2016.

Curtis KM, Tepper NK, Jatlaoui TC, et al. MMWR Recomm Rep. 2016;65(3):1-103.

Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the southern United States.

Colasanti J, Sumitani J, Mehta CC, et al. Open Forum Infect Dis. 2018;5(6):ofy104.

HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable.

Eisinger RW, Dieffenbach CW, Fauci AS. JAMA. 2019;321(5):451-452.

Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association.

Feinstein MJ, Hsue PY, Benjamin LA, et al. Circulation. 2019;140(2):e98-e124.

Linkage and antiretroviral therapy within 72 hours at a Federally Qualified Health Center in New Orleans.

Halperin J, Butler I, Connor K, et al. AIDS Patient Care STDS. 2018;32(2):39-41.

A care continuum of immediate ART for newly diagnosed patients and patients presenting later to care at a Federally Qualified Health Center in New Orleans.

Halperin J, Conner K, Butler I, et al. Open Forum Infect Dis. 2019;6(4):ofz161.

Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.

Halloran MO, Boyle C, Kehoe B, et al. Antivir Ther. 2019;24(3):193-201.

Neuropsychiatric adverse events with dolutegravir and other integrase strand transfer inhibitors.

Hoffmann C, Llibre JM. AIDS Rev. 2019;21(1):4-10.

Human immunodeficiency virus and trans women: a literature review.

Jaspal R, Kennedy L, Tariq S. Transgend Health. 2018;3(1):239-250.

The impact of comorbidities, depression, and substance use problems on quality of life among older adults living with HIV.

Millar BM, Starks TJ, Gurung S, Parsons JT. AIDS Behav. 2017;21(6):1684-1690.

Ageing and inflammation in patients with HIV infection.

Nasi M, De Biasi S, Gibellini L, et al. Clin Exp Immunol. 2017;187(1):44-52.

The effect of same-day observed initiation of antiretroviral therapy on HIV viral load and treatment outcomes in a US public health setting.

Pilcher CD, Ospina-Norvell C, Dasgupta A, et al. J Acquir Immune Defic Syndr. 2017;74(1):44-51.

Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials.

Sax PE, Erlandson KM, Lake JE, et al. Clin Infect Dis. 2020;71(6):1379-1389.

Current challenges and solutions in research and clinical care of older persons living with HIV: findings presented at the 9th International Workshop on HIV and Aging.

Sundermann EE, Erlandson KM, Pope CN, et al. AIDS Res Hum Retroviruses. 2019;35(11-12):985-998.

HIV and aging.

Wing EJ. Int J Infect Dis. 2016;53:61-68.

HIV and ischemic heart disease.

Vachiat A, McCutcheon K, Tsabedze N, Zachariah D, Manga P. J Am Coll Cardiol. 2017;69(1):73-82.

Update on neural tube defects with antiretroviral exposure in the Tsepamo study, Botswana.

Zash R, Holmes L, Diseko M, et al. J Int AIDS Soc. 2020;23(suppl 4):183-184. Abstract OAXLB0102.